Transcatheter Arterial Chemoembolization Combined with Interferon-α is Safe and Effective for Patients with Hepatocellular Carcinoma after Curative Resection |
Zuo, Chaohui
(Department of Gastroduodenal and Pancreatic Surgery, Translation Medicine Research Center of Liver Cancer, Hunan Province Cancer Hospital and Affiliated Cancer Hospital of Xiangya College)
Xia, Man (Department of Gastroduodenal and Pancreatic Surgery, Translation Medicine Research Center of Liver Cancer, Hunan Province Cancer Hospital and Affiliated Cancer Hospital of Xiangya College) Liu, Jingshi (Department of Gastroduodenal and Pancreatic Surgery, Translation Medicine Research Center of Liver Cancer, Hunan Province Cancer Hospital and Affiliated Cancer Hospital of Xiangya College) Qiu, Xiaoxin (Department of Gastroduodenal and Pancreatic Surgery, Translation Medicine Research Center of Liver Cancer, Hunan Province Cancer Hospital and Affiliated Cancer Hospital of Xiangya College) Lei, Xiong (Department of General Surgery, The Second Xiangya Hospital, Central South University) Xu, Ruocai (Department of Gastroduodenal and Pancreatic Surgery, Translation Medicine Research Center of Liver Cancer, Hunan Province Cancer Hospital and Affiliated Cancer Hospital of Xiangya College) Liu, Hanchun (Department of Gastroduodenal and Pancreatic Surgery, Translation Medicine Research Center of Liver Cancer, Hunan Province Cancer Hospital and Affiliated Cancer Hospital of Xiangya College) Li, Jianliang (Department of Gastroduodenal and Pancreatic Surgery, Translation Medicine Research Center of Liver Cancer, Hunan Province Cancer Hospital and Affiliated Cancer Hospital of Xiangya College) Li, Yongguo (Department of General Surgery, The Second Xiangya Hospital, Central South University) Li, Qinglong (Department of General Surgery, The Second Xiangya Hospital, Central South University) Xiao, Hua (Department of Gastroduodenal and Pancreatic Surgery, Translation Medicine Research Center of Liver Cancer, Hunan Province Cancer Hospital and Affiliated Cancer Hospital of Xiangya College) Hong, Yuan (Department of Gastroduodenal and Pancreatic Surgery, Translation Medicine Research Center of Liver Cancer, Hunan Province Cancer Hospital and Affiliated Cancer Hospital of Xiangya College) Wang, Xiaohong (Department of Gastroduodenal and Pancreatic Surgery, Translation Medicine Research Center of Liver Cancer, Hunan Province Cancer Hospital and Affiliated Cancer Hospital of Xiangya College) Zhu, Haizhen (Department of Gastroduodenal and Pancreatic Surgery, Translation Medicine Research Center of Liver Cancer, Hunan Province Cancer Hospital and Affiliated Cancer Hospital of Xiangya College) Wu, Qunfeng (Department of Pathology, Immunology and Laboratory Medicine and Shands Cancer Center, University of Florida) Burns, Michael (Department of Pathology, Immunology and Laboratory Medicine and Shands Cancer Center, University of Florida) Liu, Chen (Department of Pathology, Immunology and Laboratory Medicine and Shands Cancer Center, University of Florida) |
1 | Breunig IM, Shaya FT, Hanna N, et al (2013). Transarterial chemoembolization treatment: association between multiple treatments, cumulative expenditures, and survival. Value Health, 16, 760-8. DOI |
2 | Chun YH, Kim SU, Park JY, et al (2011). Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. Eur J Cancer, 47, 2568-75. DOI |
3 | Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. In J Cancer, 127, 2893-917. |
4 | Fan ST, Mau Lo C, Poon RT, et al (2011). Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg, 253, 745-58. DOI |
5 | Fina RS (2012). Current and future treatment strategies for patients with advanced hepatocellular carcinoma: role of mTOR inhibition. Liver Cancer, 1, 247-56. DOI |
6 | Herzer K, Hofmann TG, Teufel A, et al (2009). IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independenity of p53. Cancer Res, 69, 855-62. DOI |
7 | Hu L, Xue F, Li Y, et al (2014). A long-term follow-up and comprehensive observation of risk and prognosis factors of recurrence and survival after resection of hepatocellular carcinoma. Cell Biochem Biophys, 69, 421-31. DOI |
8 | Huang G, Lai EC, Lau WY, et al (2013). Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels. Ann Surg, 257, 490-505. DOI |
9 | Hou J, Zhou Y, Zheng Y, et al (2014). Hepatic RIG-I predicts survival and interferon- therapeutic response in hepatocellular carcinoma. Cancer Cell, 25, 49-63. DOI |
10 | Ippolito D, Bonaffini PA, Ratti L, et al (2010). Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor. World J Gastroenterol, 16, 5993-6000. |
11 | Jemal A, Brany F, Center MM, et al (2011). Global cancer statistitics. CA Cancer J Clin, 61, 69-90. DOI |
12 | Jiang W, Zhang C, Tian Z, et al (2013). hIFN- gene modification augments human natural killer cell line anti-human hepatocellular carcinoma function. Gene Ther, 20, 1062-9. DOI |
13 | Jianyong L, Jinjing Z, Wentao W, et al (2014). Preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: a single center analysis. Ann Hepatol, 13, 394-402. |
14 | Kumamoto T, TanakaK, Matsuo K, et al (2013). Adjuvant hepatic arterial infusion chemotherapy with 5-Fluorouracil and interferon after curative resection of hepatocellular carcinoma: a preliminary report. Anticancer Res, 33, 5585-90. |
15 | Ji J, Shi J, Budhu A, et al (2009). MicroRNA expression, survival, and response to interferon in liver cancer. N Eng J Med, 361, 1437-47. DOI |
16 | Kurth T, Walker AM, Glynn RJ, et al (2006). Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol, 163, 262-70. |
17 | Kim KM, Kim JH, Park IS, et al (2009). Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion. J Gastroenterol Hepatol, 24, 806-14. DOI |
18 | Lin S, Hoffmann K, Schemmer P (2012). Treatment of hepatocellular carcinoma review. Liver Cancer, 1, 144-58. DOI |
19 | Li KW, Li X, Wen TF, et al (2013). The effect of postoperative TACE on prognosis of HCC: an update. Hepatogastroenterology, 60, 248-51. |
20 | Li H, Hu Y, Li N, Zhou Y (2012). Liver fibrosis and five year survival of hepatocellular cancer cases undergoing transcatheter arterial chemo embolization using small doses. Asian Pac J Cancer Prev, 13, 1589-93. 과학기술학회마을 DOI ScienceOn |
21 | Lamm D, Brausi M, O,Donnell MA, et al (2014). Interferon alfa in the treatment paradigm for non-muscle-invasive bladder cancer. Urol Oncol, 32, 35.e21-30. |
22 | Lai CL, Yuen MF (2013). Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy. Hepatology, 57, 399-408. DOI ScienceOn |
23 | Martin R, Geller D, Espat J, et al (2012). Safety and efficacy of trans arterial chemoembolization with drug-eluting beads in hepatocellular cancer: a systematic review. Hepatogastroenterology, 59, 255-60. |
24 | Li F, Guo Z, Zhang Y, et al (2014). Postoperative adjuvant arterial chemoembolization improves the survival of hepatitis B virus-related hepatocellular carcinoma: a retrospective control study. Ir J Med Sci, 183, 688-90. |
25 | Lencioni R (2012). New progress of non-surgical treatments for hepatocellular carcinoma. Semin Oncol, 39, 503-9. DOI ScienceOn |
26 | Lin LY, Wong VW, Zhou HJ, et al (2010). Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients. J Med Virol, 82, 1495-500. |
27 | Nagano H, Sakon M, Eguchi H, et al (2007). Hepatic resection followed by IFN- and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch. Hepatogastroenterology, 54, 172-9. |
28 | Poortahmasebi V, Alavian SM, Keyvani H, et al (2014). Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infection. Asian Pac J Cancer Prev, 15, 3879-84. 과학기술학회마을 DOI |
29 | Qu LS, Jin F, Huang XW, et al (2010). Interferon- therapy after Curative resection prevents early recurrence and improves survival in patients with hepatitics B virus-related hepatocellular carcinoma. J Surg Oncol, 102, 796-801. DOI |
30 | Shen Y, Lin ZZ, Hsu CH, et al (2013). Clinical trials in Hepatocellular carcinoma: An update. Liver Cancer, 2, 345-64. DOI |
31 | Tang ZM, Sun BC (2013). Effects of antiviral therapy on preventing liver tumorigenesis and hepatocellular carcinoma recurrence. World J Gastroenterol, 19, 8895-901. DOI |
32 | Sun P, Yang X, He RQ, et al (2013). Antiviral therapy after curative treatment of hepatitis B/C virus-related hepatocellular carcinoma: A systematic review of randomized trials. Hepatol Res, 44, 259-69. |
33 | Sun HC, Tang ZY, Wan L, et al (2006). Postoperative interferon- treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. J Cancer Res Clin Oncol, 132, 458-65. DOI |
34 | Sakon M, Nagano H, Dono K, et al (2002). Combination intraarterial 5-Fluorouracil and subcutaneous interferon- therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches. Cancer, 2002, 94, 435-42. DOI |
35 | Tanaka K, Yabushita Y, Nakagawa K, et al (2013). Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study. Eur J Surg Oncol, 39, 1364-70. DOI |
36 | Xi T, Lai EC, Min AR, et al (2012). Adjuvant transatheter arterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study. Hepatogastroenterology, 59, 1198-203. |
37 | Zhong JH, Li LQ (2010). Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: a meta-analysis. Hepatol Res, 40, 943-53. DOI |
38 | Zhou YM, Zhang XF, Li B, et al (2014). Prognosis after resection of hepatitis B virus-related hepatocellular carcinoma originating from non-cirrhotic liver. Ann Surg, 21, 2406-12. DOI |